The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Pharmacyclics, Inc.

Pharmacyclics, Inc.
Nasdaq: PCYC
Change
symbol:
     
 PROFILE
Pharmacyclics rides herd on the development of drugs that enhance radiation therapy, chemotherapy, and photodynamic therapy. These drug candidates, which localize in the cells targeted for treatment, are activated by light, chemicals, or X-rays and may be used to help treat cancer, cardiovascular disease, and other conditions. The development-stage firm has licensing and development agreements with the National Cancer Institute, The University of Texas, ophthalmic firm Alcon Laboratories, and imaging-agent experts Amershame (formerly Nycomed Amersham). Pharmacyclics has developed CITRA VU, a contrast agent it has licensed to E-Z-EM.

 COMPETITION
Mallinckrodt Inc. (dossier)
Medical Resources, Inc. (MRIIQ)
QLT Inc. (QLTI)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: June
2000 Sales (mil.): 1.60
1-Yr. Sales Growth: (20.0)%
Employees: 146
Revenue per employee: $10,958.90

 KEY PEOPLE
• Richard A. Miller
    CEO
• Leiv Lea
    CFO

 CONTACT INFO
995 E. Arques Ave.
Sunnyvale, CA 94086
US
Phone: 408-774-0330
Fax: 408-774-0340
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001